US 8163737
CGRP receptor antagonists
granted A61PA61P19/02A61P25/06
Quick answer
US patent 8163737 (CGRP receptor antagonists) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P19/02, A61P25/06